These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18537518)

  • 1. Anti-inflammatory: new trends in the treatment of the patient with systemic sclerosis.
    Valentini G; Cerinic MM
    Expert Opin Emerg Drugs; 2008 Jun; 13(2):227-36. PubMed ID: 18537518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of systemic sclerosis.
    Allanore Y; Kahan A
    Joint Bone Spine; 2006 Jul; 73(4):363-8. PubMed ID: 16495105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment Algorithms for Systemic Sclerosis According to Experts.
    Fernández-Codina A; Walker KM; Pope JE;
    Arthritis Rheumatol; 2018 Nov; 70(11):1820-1828. PubMed ID: 29781586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the treatment of systemic sclerosis.
    Bournia VK; Vlachoyiannopoulos PG; Selmi C; Moutsopoulos HM; Gershwin ME
    Clin Rev Allergy Immunol; 2009 Jun; 36(2-3):176-200. PubMed ID: 19132559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of scleroderma].
    Mouthon L
    Rev Prat; 2002 Nov; 52(17):1915-7. PubMed ID: 12532869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Worldwide Expert Agreement on Updated Recommendations for the Treatment of Systemic Sclerosis.
    de Vries-Bouwstra JK; Allanore Y; Matucci-Cerinic M; Balbir-Gurman A
    J Rheumatol; 2020 Feb; 47(2):249-254. PubMed ID: 31043545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of systemic sclerosis].
    van den Hoogen FH
    Z Rheumatol; 2006 Jul; 65(4):306, 308-10. PubMed ID: 16819640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current treatment of systemic sclerosis. Part II. Vascular and antifibrotic treatment].
    Sicińska J; Rudnicka L
    Pol Merkur Lekarski; 2008 Aug; 25(146):196-200. PubMed ID: 18942347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of systemic sclerosis complications: what to use when first-line treatment fails--a consensus of systemic sclerosis experts.
    Walker KM; Pope J; ;
    Semin Arthritis Rheum; 2012 Aug; 42(1):42-55. PubMed ID: 22464314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 Patients.
    Moinzadeh P; Riemekasten G; Siegert E; Fierlbeck G; Henes J; Blank N; Melchers I; Mueller-Ladner U; Frerix M; Kreuter A; Tigges C; Lahner N; Susok L; Guenther C; Zeidler G; Pfeiffer C; Worm M; Karrer S; Aberer E; Bretterklieber A; Genth E; Simon JC; Distler JH; Hein R; Schneider M; Seitz CS; Herink C; Steinbrink K; Sárdy M; Varga R; Mensing H; Mensing C; Lehmann P; Neeck G; Fiehn C; Weber M; Goebeler M; Burkhardt H; Buslau M; Ahmadi-Simab K; Himsel A; Juche A; Koetter I; Kuhn A; Sticherling M; Hellmich M; Kuhr K; Krieg T; Ehrchen J; Sunderkoetter C; Hunzelmann N;
    J Rheumatol; 2016 Jan; 43(1):66-74. PubMed ID: 26568599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting vascular disease in systemic sclerosis.
    Kowal-Bielecka O
    Endocr Metab Immune Disord Drug Targets; 2006 Dec; 6(4):401-7. PubMed ID: 17214586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic sclerosis - a systematic overview: part 2 - immunosuppression, treatment of SSc-associated vasculopathy, and treatment of pulmonary arterial hypertension.
    Opitz C; Klein-Weigel PF; Riemekasten G
    Vasa; 2011 Jan; 40(1):20-30. PubMed ID: 21283970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current treatment of systemic sclerosis. Part I. Immunosuppressive treatment].
    Sicińska J; Rudnicka L
    Pol Merkur Lekarski; 2008 Aug; 25(146):192-5. PubMed ID: 18942346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive treatment of the pulmonary manifestations of progressive systemic sclerosis.
    Vallance DK; Lynch JP; McCune WJ
    Curr Opin Rheumatol; 1995 May; 7(3):174-82. PubMed ID: 7612408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort.
    Panopoulos S; Chatzidionysiou Κ; Tektonidou MG; Bournia VK; Drosos AA; Liossis SC; Dimitroulas T; Sakkas L; Boumpas D; Voulgari PV; Daoussis D; Thomas K; Georgiopoulos G; Vosvotekas G; Garyfallos Α; Sidiropoulos P; Bertsias G; Vassilopoulos D; Sfikakis PP
    Arthritis Res Ther; 2020 Mar; 22(1):56. PubMed ID: 32293545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expert agreement on EULAR/EUSTAR recommendations for the management of systemic sclerosis.
    Walker KM; Pope J; ;
    J Rheumatol; 2011 Jul; 38(7):1326-8. PubMed ID: 21459952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term treatments for systemic sclerosis: what are the perspectives?].
    Mouthon L; Agard C; Garcia De La Peña-Lefebvre P; Guillevin L
    Ann Med Interne (Paris); 2002 Jun; 153(4):265-75. PubMed ID: 12218893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted therapy for systemic sclerosis.
    Steen V
    Autoimmun Rev; 2006 Feb; 5(2):122-4. PubMed ID: 16431341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agreement with guidelines from a large database for management of systemic sclerosis: results from the Canadian Scleroderma Research Group.
    Pope J; Harding S; Khimdas S; Bonner A; ; Baron M
    J Rheumatol; 2012 Mar; 39(3):524-31. PubMed ID: 22247347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The changing face of severe scleroderma in five patients.
    Spooner MS; LeRoy EC
    Clin Exp Rheumatol; 1990; 8(4):341-5. PubMed ID: 2397623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.